BCRABL Quantitative MRD Monitor Test
Introduction to the BCRABL Quantitative MRD Monitor Test
The BCRABL Quantitative MRD Monitor Test is a pivotal diagnostic tool used in the management of leukemia, particularly in patients with BCR-ABL positive chronic myeloid leukemia (CML). This test provides critical insights into the effectiveness of treatment regimens by quantifying the levels of minimal residual disease (MRD). Monitoring MRD is essential for ensuring that the treatment is effective and for making necessary adjustments to therapy.
What the Test Measures
This test measures the quantity of BCR-ABL fusion gene transcripts in a patient’s blood or bone marrow. The presence of this gene is indicative of leukemia, and tracking its levels can help determine how well a patient is responding to treatment.
Who Should Consider This Test
The BCRABL Quantitative MRD Monitor Test is recommended for:
- Patients diagnosed with BCR-ABL positive leukemia.
- Individuals undergoing treatment for leukemia who need ongoing monitoring.
- Patients who have completed initial treatment and require follow-up assessments.
Symptoms that may warrant this test include fatigue, unexplained weight loss, and recurrent infections, which may indicate a relapse or persistence of the disease.
Benefits of Taking the Test
- Allows for precise monitoring of disease progression or remission.
- Enables healthcare providers to tailor treatment plans based on MRD levels.
- Helps in early detection of potential relapses, improving patient outcomes.
- Provides reassurance to patients and families regarding treatment efficacy.
Understanding Your Results
Results from the BCRABL Quantitative MRD Monitor Test are typically reported as the number of BCR-ABL transcripts per million ABL transcripts. A decrease in this ratio indicates effective treatment, while an increase may suggest a need for further intervention. It is crucial to discuss your results with your healthcare provider to understand their implications fully.
Test Pricing
| Price Type | Amount (NGN) |
|---|---|
| Discount Price | 164,000 |
| Regular Price | 220,000 |
Booking the Test
To book the BCRABL Quantitative MRD Monitor Test, please contact us at +2348077798758 or visit our website for more information. Ensure you bring a duly filled MRD Requisition Form (Form 22) with historical data when you come for your test.
Sample Collection and Turnaround Time
Sample type: 5 mL (3 mL min.) whole blood or bone marrow in 1 Lavender Top (EDTA) tube. Ship refrigerated. DO NOT FREEZE. The turnaround time for results is typically 3 days, with samples collected on Mondays, Wednesdays, and Fridays by 9 AM, and reports available on Tuesdays, Thursdays, and Saturdays.
For further inquiries or to schedule your appointment, feel free to reach out via phone or WhatsApp at +2348077798758.
